GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » EBITDA Margin %

Sunflower Pharmaceutical Group Co (SZSE:002737) EBITDA Margin % : 22.25% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sunflower Pharmaceutical Group Co's EBITDA for the three months ended in Mar. 2024 was ¥338 Mil. Sunflower Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2024 was ¥1,518 Mil. Therefore, Sunflower Pharmaceutical Group Co's EBITDA margin for the quarter that ended in Mar. 2024 was 22.25%.


Sunflower Pharmaceutical Group Co EBITDA Margin % Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co EBITDA Margin % Chart

Sunflower Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.50 26.67 24.04 26.69 27.05

Sunflower Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.34 23.80 18.39 21.84 22.25

Competitive Comparison of Sunflower Pharmaceutical Group Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sunflower Pharmaceutical Group Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunflower Pharmaceutical Group Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunflower Pharmaceutical Group Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sunflower Pharmaceutical Group Co's EBITDA Margin % falls into.



Sunflower Pharmaceutical Group Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sunflower Pharmaceutical Group Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1541.939/5700.287
=27.05 %

Sunflower Pharmaceutical Group Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=337.826/1518.181
=22.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunflower Pharmaceutical Group Co  (SZSE:002737) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Sunflower Pharmaceutical Group Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunflower Pharmaceutical Group Co (SZSE:002737) Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Executives
Liu Tian Wei Director
Guan Yu Xiu Director
Wu Guo Xiang Executives
Ren Jing Shang Directors, executives
Guan Yan Bin Directors, executives
Wan Yun Guo Executives
Tian Yan Secretary Dong
Tan Chang Executives
Zhang Quan Director
Xu Qing Fen Supervisors
Jiang Feng He Supervisors
Wu Shu Hua Director
Guan Yan Ling Director
Zhou Jian Zhong Executives

Sunflower Pharmaceutical Group Co (SZSE:002737) Headlines

No Headlines